We are live on ! Find out more
MMPI

Morgenthaler Management Partners IX Portfolio holdings

AUM $22.6M
This Fund
S&P 500
This Quarter Est. Return
+12.95%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$46.9M
AUM Growth
-$78.3M
Cap. Flow
-$87.4M
Cap. Flow %
-186.48%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
PRNB
Principia Biopharma Inc. Common Stock
PRNB
+$60.1M
2
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$27.3M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RARX
1
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$27.5M 58.79%
1,229,782
-1,267,770
-51% -$27.3M
VAPO
2
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$19.3M 41.21%
122,836
– –
PRNB
3
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
– –
-2,195,125
Closed -$60.1M

Similar funds

DPA
Delphi Private Advisors San Diego, California $19.6M AUM 1.25% 1-Year Est. Return
HCA
Hillview Capital Advisors Wayne, Pennsylvania $18.8M AUM 1.7% 1-Year Est. Return
TCM
TVR Capital Management Stamford, Connecticut $16.3M AUM 45.87% 1-Year Est. Return
AC
Argentiere Capital Zug, Switzerland $15.4M AUM 8.82% 1-Year Est. Return
MP
Manifold Partners San Francisco, California $10.4M AUM 5.49% 1-Year Est. Return
WAM
WIM Asset Management Hong Kong $35.6M AUM
AF
Aristotle Fund Portland, Maine $6.27M AUM 17.13% 1-Year Est. Return
KAM
Kassirer Asset Management Toronto, Ontario, Canada $4.07M AUM 49.71% 1-Year Est. Return

Morgenthaler Management Partners IX's Q1 2019 Portfolio in Review

As of Q1 2019, Morgenthaler Management Partners IX held 3 positions worth $46.9M, down 63% from $125M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Morgenthaler Management Partners IX withdrew a net $87.4M in Q1 2019, closing 1 position and reducing 1 holding. Its most notable exit was Principia Biopharma Inc. Common Stock, an estimated $60.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Morgenthaler Management Partners IX's biggest Q1 2019 reduction was Ra Pharmaceuticals, Inc. Common Stock, cutting an estimated $27.3M.
  • Morgenthaler Management Partners IX fully exited Principia Biopharma Inc. Common Stock in Q1 2019, selling an estimated $60.1M.
  • Morgenthaler Management Partners IX's ten largest holdings make up 100% of its $46.9M portfolio in Q1 2019.
  • Morgenthaler Management Partners IX opened 0 new positions and closed 1 in Q1 2019.
  • Morgenthaler Management Partners IX's portfolio value fell 63% quarter-over-quarter to $46.9M.

Based on Morgenthaler Management Partners IX's 13F filing for Q1 2019, filed 15 May 2019.